Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?

about

Are we a step forward with targeted agents in resolving the enigma of mantle cell lymphoma?

Item

http://www.wikidata.org/entity/Q38382492

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Are we a step forward with tar ...... nigma of mantle cell lymphoma?

@en

type

Item

label

Are we a step forward with tar ...... nigma of mantle cell lymphoma?

@en

prefLabel

Are we a step forward with tar ...... nigma of mantle cell lymphoma?

@en

P1476

Are we a step forward with tar ...... nigma of mantle cell lymphoma?

@en

P2093

Ivica Pejčić

http://www.w3.org/2001/XMLSchema#string

Svetislav Vrbić

http://www.w3.org/2001/XMLSchema#string

P2860

A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group

A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma

Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma

Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphoma.

Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma: a phase 2 trial in the North Central Cancer Treatment Group

Phase III study to evaluate temsirolimus compared with investigator's choice therapy for the treatment of relapsed or refractory mantle cell lymphoma.

Temsirolimus in mantle cell lymphoma and other non-Hodgkin lymphoma subtypes.

P304

377-383

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2014.45111

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ivan Petković

P577

2014-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273784754

http://www.w3.org/2001/XMLSchema#string

P698

25784834

http://www.w3.org/2001/XMLSchema#string

P932

4355653

http://www.w3.org/2001/XMLSchema#string